Productivity of three sugarcane cultivars under dry and drip irrigated management

O objetivo neste trabalho foi estudar o efeito da tecnologia de irrigação por gotejamento, em cultivares de cana-de-açúcar, em dois ciclos de produção (cana-planta e cana-soca). O delineamento experimental utilizado foi o de blocos ao acaso, com quatro repetições, constituídos pela combinação de três cultivares de cana-de-açúcar: RB867515; RB855536 e SP80-3280, e dois manejos da cultura: sistema de irrigação por gotejamento subterrâneo e sistema de sequeiro, totalizando seis tratamentos. O primeiro ciclo teve duração de 336 dias, ocorrendo precipitação de 1.480 mm. O volume de água disponibilizado pelo sistema de irrigação por gotejamento foi de 400 mm, totalizando 1.880 mm. O segundo ciclo teve duração de 365 dias, cujo volume de água por meio de precipitação foi de 1.394 mm; somados aos 320 mm fornecidos pelo sistema de irrigação, totalizaram 1.714 mm. Ocorreu interação entre manejo e cultivar para as variáveis: produtividade de colmos (TCH) e produtividade de açúcar (TPH) em que a maior diferença foi observada para a cultivar SP80-3280. As cultivares apresentaram respostas diferenciadas na eficiência de utilização da água. No manejo irrigado por gotejamento houve elevação de 24% na produtividade de colmos e de 23% na produtividade de açúcar, em relação ao manejo de sequeiro.This study aimed to evaluate the effect of drip irrigation technology in different sugarcane varieties in two crop cycles (plant cane and ratoon). The experimental design was in completly randomized blocks, in split-plot with four replications, constituted by three sugarcane genotypes: RB867515; RB855536 and SP80-3280 and two crop management: drip irrigation system and rainfed system, totalizing six treatments. The first cycle lasted for 336 days, with rainfall of 1,480 mm. The volume of water provided by the system of drip irrigation was 400 mm, totaling 1,880 mm. The second cycle lasted for 365 days, the volume of water through rainfall was 1,394 mm, added to 320 mm provided by the system of irrigation, totaled 1,714 mm. Interaction between management and cultivars was found significant for the variables: productivity of stalks (TCH) and sugar yield (TPH), in which the largest difference was observed for cultivar SP80-3280. There was significant response to drip irrigation, on average the increase of production of stalks and sugar was 24 and 23%, respectively

Drug release mechanisms of chemically cross-linked albumin microparticles: effect of the matrix erosion

Albumin (BSA) microparticles were developed as a biotechnological alternative for drug delivery. Vitamin B12 (Vit-B12) was used as a model drug. The microparticles were obtained from maleic anhydride-functionalized BSA and N′,N′-dimethylacrylamide (DMAAm) in a W/O emulsion without and with PVA. The microparticles produced at 15 min of stirring without PVA showed the best results in terms of size, homogeneity, and sphericity. In such a case, BSA played a role as a surface active agent, replacing PVA. For longer stirring times, BSA was unable to act as an emulsifier. These microparticles showed an uncommon release profile, consisting of a two-step release mechanism, at the pH range studied. Considering that a two-step release mechanism is occurring, the experimental data were adjusted by applying modified power law and Weibull equations in order to describe release mechanism n and release rate constant k, respectively. Each one of the release stages was related to a specific value of n and k. The second stage was driven by a super case II transport mechanism, as a result of diffusion, macromolecular relaxation, and erosion. A third model, described by Hixson–Crowell, confirmed the erosion mechanism. Vit-B12 diffusion kinetics in aqueous solutions (i.e., without the microparticles) follows a one-step process, being k dependent on the pH, confirming that the two-step release mechanism is a characteristic profile of the developed microparticles. The microparticles released only 2.70% of their initial drug load at pH 2, and 58.53% at pH 10

Imbalance of NET and Alpha-1-Antitrypsin in Tuberculosis Patients Is Related With Hyper Inflammation and Severe Lung Tissue Damage

Background: Pulmonary tuberculosis (PTB) can lead to lung tissue damage (LTD) and compromise the pulmonary capacity of TB patients that evolve to severe PTB. The molecular mechanisms involved in LTD during anti-tuberculous treatment (ATT) remain poorly understood.Methods and findings: We evaluated the role of neutrophil extracellular trap (NET) and the occurrence of LTD through chest radiographic images, the microbial load in sputum, and inflammatory serum profile (IL-12p40/p70, IL-8, IL-17A, IL-23, VEGF-A, MMP-1, and -8, galectin-3, citrunillated histone H3—cit-H3, alpha-1-antitrypsin—α1AT, C-reactive protein—CRP and albumin) in a cohort of 82 PTB patients before and after 60 days of ATT. Using univariate analysis, LTD was associated with neutrophilia and increase of several inflammatory proteins involved in the neutrophil-mediated response, being cit-H3 the more related to the event. In the multivariate analysis, neutrophilia and cit-H3 appear as directly related to LTD. The analysis of the ROC curve at day 60 presented AUC of 0.97 (95.0% CI 0.95–1). Interestingly, at day 0 of ATT, these biomarkers demonstrated fine relation with LTD showing an AUC 0.92 (95.0% CI 0.86–0.99). Despite of that, the same molecules have no impact in culture conversion during ATT.Conclusions: Our data revealed that NETs may play a key role in the pathway responsible for non-specific inflammation and tissue destruction in PTB. High level of cit-H3 and low level of α1AT was observed in the serum of severe TB patients, suggesting a breakdown in the intrinsic control of NET-driven tissue damage. These data show a new insight to knowledge TB immunopathogenesis, the role of neutrophil and NET pathway. Likewise, we identified possible biomarkers to screening of PTB patients eligible to adjuvants therapies, as anti-inflammatories and alpha-1-antitrypsin

Medidas diretas de atividade física em crianças e cumprimento das recomendações da Organização Mundial de Saúde

Os objetivos deste estudo foram verificar a quantidade e intensidade de prática de atividade física (AF) em crianças de baixo nível socioeconômico, e avaliar o cumprimento das recomendações da Organização Mundial de Saúde (AF moderada a vigorosa ≥ 60 minutos diários) nos dias de semana e finais de semana. Participaram do estudo 174 crianças (49% meninas) entre 7 e 10 anos de idade, residentes em área de vulnerabilidade social. O tempo e intensidade da AF foram medidos com acelerômetros (wGT3X+), durante 7 dias consecutivos, e para caracterizar a AF moderada a vigorosa (AFMV) foi utilizado um ponto de corte ≥ 2296 contagens por minuto. As comparações entre os sexos foram realizadas por meio da Análise de Variância, utilizando-se ainda o Teste t para medidas dependentes para as comparações entre a AFMV praticada durante a semana e os finais de semana, e o teste qui-quadrado para verificar as associações entre as variáveis sexo e cumprimento das diretrizes internacionais de atividade física. Em média, os meninos realizaram mais AFMV do que as meninas (p < 0,01), tanto em dias de semana (77 x 58 minutos por dia) como nos finais de semana (71 x 50 minutos por dia). Durante os dias de semana, 59% das crianças atingiram as recomendações (72% dos meninos e 42% das meninas; p < 0,001) e apenas 47% (57% dos meninos e 34% das meninas; p < 0,001) atingiramas recomendações durante os finais de semana. Esses dados reforçam a necessidade de ampliação da oferta de atividades físicas voltadas à realidade sociocultural da criança, com atenção especial para as meninas e para um maior envolvimento das famílias, particularmente durante os finais de semana

Protective action of N-acetyl-L-cysteine associated with a polyvalent antivenom on the envenomation induced by Lachesis muta muta (South American bushmaster) in rats

In this study, we examined the potential use of N-acetyl-L-cysteine (NAC) in association with a polyvalent antivenom and as stand-alone therapy to reduce the acute local and systemic effects induced by Lachesis muta muta venom in rats. Male Wistar rats (300–350 g) were exposed to L. m. muta venom (1.5 mg/kg – i.m.) and subsequently treated with anti-Bothrops/Lachesis serum (antivenom:venom ratio 1:3 ‘v/w’ – i.p.) and NAC (150 mg/kg – i.p.) separately or in association; the animals were monitored for 120 min to assess changes in temperature, locomotor activity, local oedema formation and the prevalence of haemorrhaging. After this time, animals were anesthetized in order to collect blood samples through intracardiac puncture and then euthanized for collecting tissue samples; the hematological-biochemical and histopathological analyses were performed through conventional methods. L. m. muta venom produced pronounced local oedema, subcutaneous haemorrhage and myonecrosis, with both antivenom and NAC successfully reducing the extent of the myonecrotic lesion when individually administered; their association also prevented the occurrence of subcutaneous haemorrhage. Venom-induced creatine kinase (CK) release was significantly prevented by NAC alone or in combination with antivenom; NAC alone failed to reduce the release of hepatotoxic (alanine aminotransferase) and nephrotoxic (creatinine) serum biomarkers induced by L. m. muta venom. Venom induced significant increase of leucocytes which was also associated with an increase of neutrophils, eosinophils and monocytes; antivenom and NAC partially reduced these alterations, with NAC alone significantly preventing the increase of eosinophils whereas neither NAC or antivenom prevented the increase in monocytes. Venom did not induce changes in the erythrogram parameters. In the absence of a suitable antivenom, NAC has the potential to reduce a number of local and systemic effects caused by L. m. muta venom

Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study

Purpose: Drug utilization research (DUR) contributes to inform policymaking and to strengthen health systems. The availability of data sources is the first step for conducting DUR. However, documents that systematize these data sources in Latin American (LatAm) countries are not known. We compiled the potential data sources for DUR in the LatAm region. Methods: A network of DUR experts from nine LatAm countries was assembled and experts conducted: (i) a website search of the government, academic, and private health institutions; (ii) screening of eligible data sources, and (iii) liaising with national experts in pharmacoepidemiology (via an online survey). The data sources were characterized by accessibility, geographic granularity, setting, sector of the data, sources and type of the data. Descriptive analyses were performed. Results: We identified 125 data sources for DUR in nine LatAm countries. Thirty-eight (30%) of them were publicly and conveniently available; 89 (71%) were accessible with limitations, and 18 (14%) were not accessible or lacked clear rules for data access. From the 125 data sources, 76 (61%) were from the public sector only; 46 (37%) were from pharmacy records; 43 (34%) came from ambulatory settings and; 85 (68%) gave access to individual patient-level data. Conclusions: Although multiple sources for DUR are available in LatAm countries, the accessibility is a major challenge. The procedures for accessing DUR data should be transparent, feasible, affordable, and protocol-driven. This inventory could permit a comparison of drug utilization between countries identifying potential medication-related problems that need further exploration.Fil: Lopes, Luciane C.. University Of Sorocaba; BrasilFil: Salas, Daiana Maribel. University of Pennsylvania; Estados UnidosFil: Osorio de Castro, Claudia Garcia Serpa. Fundación Oswaldo Cruz; BrasilFil: Freitas Leal, Lisiane. McGill University; CanadáFil: Doubova, Svetlana V.. Mexican Institute of Social Security; MéxicoFil: Cañás, Martín. Universidad Nacional Arturo Jauretche; Argentina. Federación Médica de la Provincia de Buenos Aires; ArgentinaFil: Dreser, Anahi. Instituto Nacional de Salud Pública; MéxicoFil: Acosta, Angela. Universidad ICESI; ColombiaFil: Oliveira Baldoni, Andre. Federal University of São João Del-Rei; BrasilFil: de Cássia Bergamaschi, Cristiane. University of Sorocaba; BrasilFil: Marques Mota, Daniel. Brazilian Health Regulatory Agency; BrasilFil: Gómez Galicia, Diana L.. Universidad Autónoma del Estado de Morelos; MéxicoFil: Sepúlveda Viveros, Dino. Universidad de Chile; ChileFil: Narvaez Delgado, Edgard. No especifíca;Fil: da Costa Lima, Elisangela. Universidade Federal do Rio de Janeiro; BrasilFil: Chandia, Felipe Vera. Pontificia Universidad Católica de Chile; ChileFil: Ferre, Felipe. Universidade Federal de Minas Gerais; BrasilFil: Marin, Gustavo Horacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata; ArgentinaFil: Olmos, Ismael. State Health Services Administration; UruguayFil: Zimmermann, Ivan R.. Universidade do Brasília; BrasilFil: Fulone, Izabela. University of Sorocaba; BrasilFil: Roldán Saelzer, Juan. Instituto de Salud Pública; ChileFil: Sánchez Salgado, Juan Carlos. No especifíca;Fil: Castro Pastrana, Lucila I.. Universidad de Las Américas de Puebla; MéxicoFil: de Souza, Luiz Jupiter Carneiro. Fundación Oswaldo Cruz; BrasilFil: Machado Beltrán, Manuel. Universidad Nacional de Colombia; ColombiaFil: Tolentino Silva, Marcus. University of Sorocaba; BrasilFil: Mena, María Belén. Universidad Central del Ecuador; EcuadorFil: de França Fonteles, Marta Maria. Universidade Federal do Ceara; BrasilFil: Urtasun, Martín Alejandro. Universidad Nacional Arturo Jauretche; Argentina. Federación Médica de la Provincia de Buenos Aires; Argentin